Skip to main content
. 2021 Mar 30;9:656741. doi: 10.3389/fcell.2021.656741

FIGURE 3.

FIGURE 3

Disease-free survival (DFS) and overall survival (OS) for the prognostic nutritional index (PNI) of patients with breast cancer in different molecular subtypes. (A,B) Kaplan–Meier analysis of DFS (A) and OS (B) for the PNI of patients with luminal A breast cancer in all enrolled patients. (C,D) Kaplan–Meier analysis of DFS (C) and OS (D) for the PNI of patients with luminal B HER2-positive breast cancer in all enrolled patients. (E,F) Kaplan–Meier analysis of DFS (E) and OS (F) for the PNI of patients with luminal B HER2-negative breast cancer in all enrolled patients. (G,H) Kaplan–Meier analysis of DFS (G) and OS (H) for the PNI of patients with HER2-enriched breast cancer in all enrolled patients. (I,J) Kaplan–Meier analysis of DFS (I) and OS (J) for the PNI of patients with triple-negative breast cancer in all enrolled patients.